Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Revvity Inc before investing.
In this article, we go over a few key elements for understanding Revvity Inc’s stock price such as:
- Revvity Inc’s current stock price and volume
- Why Revvity Inc’s stock price changed recently
- Upgrades and downgrades for RVTY from analysts
- RVTY’s stock price momentum as measured by its relative strength
About Revvity Inc
(RVTY)
Before we jump into Revvity Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
Want to learn more about Revvity Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Revvity Inc.
Revvity Inc’s Stock Price as of Market Close
As of April 09, 2024, 4:02 PM, CST, Revvity Inc’s stock price was $110.72.
Revvity Inc is up 4.05% from its previous closing price of $106.41.
During the last market session, Revvity Inc’s stock traded between $102.12 and $106.96. Currently, there are 123.33 million shares of Revvity Inc stock available for purchase.
Revvity Inc’s price-earnings (P/E) ratio is currently at 73.9, which is high compared to the Advanced Medical Equipment & Technology industry median of 37.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.
Revvity Inc Stock Price History
Revvity Inc’s
(RVTY) price is currently up 5.45% so far this month.
During the month of April, Revvity Inc’s stock price has reached a high of $110.82 and a low of $100.96.
Over the last year, Revvity Inc has hit prices as high as $139.04 and as low as $79.50. Year to date, Revvity Inc’s stock is down 21.04%.
Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions
What Caused Revvity Inc Stock’s Price to Rise?
Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?
When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 08, 2024, there were 2 analysts who downgraded Revvity Inc’s stock and 8 analysts who upgraded over the last month.
Additionally, you'll want to evaluate Revvity Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Revvity Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.
Revvity Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.
Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.
Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Revvity Inc
(RVTY) by visiting AAII Stock Evaluator.
Relative Price Strength of Revvity Inc
Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.
For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.
As of April 08, 2024, Revvity Inc has a weighted four-quarter relative price strength of -10.81%, which translates to a Momentum Score of 31 and is considered to be Weak.
Want to learn more about how Revvity Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.
Revvity Inc Stock Price: Bottom Line
As of April 9, 2024, Revvity Inc’s stock price is $110.72, which is up 4.05% from its previous closing price.
AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Revvity Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.
Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.
Included With AAII Platinum
at only 6.9%
Gain Since Inception. Data as of 12/31/2024.
769.3% Stock Superstars Portfolio Total Return Since Inception
U.S. Index ETF (IYY)
SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.
FREE REPORT
BECOME A MEMBER FOR ONLY $2
Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.